Cargando…
Prospective validation of CD4(+) CD25(+) FOXP3(+) T-regulatory cells as an immunological marker to differentiate intestinal tuberculosis from Crohn’s disease
BACKGROUND/AIMS: Crohn’s disease (CD) and intestinal tuberculosis (ITB) remain “difficult-to-differentiate” diseases. We have previously documented peripheral blood frequency of CD4(+) CD25(+) FOXP3(+) T-regulatory cells (Treg) as a biomarker to differentiate CD and ITB. We tried to validate these r...
Autores principales: | Rampal, Ritika, Kedia, Saurabh, Wari, Mohamad Nahidul, Madhu, Deepak, Singh, Amit Kumar, Tiwari, Veena, Mouli, V. Pratap, Mohta, Srikant, Makharia, Govind, Ahuja, Vineet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Korean Association for the Study of Intestinal Diseases
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8100372/ https://www.ncbi.nlm.nih.gov/pubmed/32375209 http://dx.doi.org/10.5217/ir.2019.09181 |
Ejemplares similares
-
CD4(+) CD25(+) FOXP3(+) T cell frequency in the peripheral blood is a biomarker that distinguishes intestinal tuberculosis from Crohn’s disease
por: Tiwari, Veena, et al.
Publicado: (2018) -
Urinary potassium is a potential biomarker of disease activity in Ulcerative colitis and displays in vitro immunotolerant role
por: Goyal, Sandeep, et al.
Publicado: (2017) -
Prevalence and Association of Mycobacterium avium subspecies paratuberculosis with Disease Course in Patients with Ulcero-Constrictive Ileocolonic Disease
por: Khan, Imteyaz Ahmad, et al.
Publicado: (2016) -
Low dose oral curcumin is not effective in induction of remission in mild to moderate ulcerative colitis: Results from a randomized double blind placebo controlled trial
por: Kedia, Saurabh, et al.
Publicado: (2017) -
Interferon-gamma release assay has poor diagnostic accuracy in differentiating intestinal tuberculosis from Crohn’s disease in tuberculosis endemic areas
por: Sachdeva, Karan, et al.
Publicado: (2023)